Media Releases › Chimeric Therapeutics View All Chimeric Therapeutics News Chimeric Therapeutics - Security Class Reinstatement to Quotation CHMO 28 Mar 2022 08:46 AM The suspension of trading in the options (ASX: CHMO) of Chimeric Therapeutics Limited (‘CHM’) will be lifted immediately. For more information, download the attached PDF. Download this document
